Published May 7, 2021, 3:15 PM
The recruitment of participants for clinical trial on the use of sleep-aid supplement melatonin as adjuvant treatment for coronavirus disease (COVID-19) in patients with pneumonia is ongoing, the Department of Science and Technology (DOST) has disclosed.
DOST Secretary Fortunato “Boy” T. de la Peña said the melatonin clinical trial is headed by Dr. Camilo C. Roa Jr. of the Manila Doctors Hospital and is implemented for nine months, from Sept. 7, 2020 to June 6, 2021.
(Manila Bulletin File Photo)
“Currently, recruitment of participants is ongoing,” he said.
He said the project has already started the recruitment in 12 out of the 17 hospital sites.
3 more Chinese vaccine developers apply for COVID-19 vaccine trials in PH mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
Tawa-tawa (Manila Bulletin File Photo)
This was disclosed by Department of Science and Technology (DOST) Secretary Fortunato “Boy” T. de la Peña during President Duterte’s televised briefing on late Wednesday night, April 5.
“Two-hundred eighty patients po, actually ang targeted start ng pag-aadminister ay May 5 (The target participants are 280 patients, the targeted start to administer it is on May 5 ,” he reported to Duterte.
He said the project is led by Dr. Philip Ian Padilla of the University of the Philippines (UP) Visayas and will be implemented for 11 months.
“It aims to determine the efficacy of standardised aqueous Euphorbia hirta L. spray-dried extract (SDE)- previously developed with the support of DOST-PCHRD Tuklas Lunas Program- as an adjunctive treatment for mild to moderate cases of COVID-19,” de la Peña said.
Published May 6, 2021, 9:11 PM
The Commission on Audit (COA) has questioned the Davao City government’s assets amounting to more than P9.48 billion or 40 percent of its total assets recorded as of Dec. 31, 2020 as well as its millions of coronavirus disease (COVID-19) disbursements last year.
COA (Manila Bulletin File Photo)
Based on the 2020 audit of the Davao City released on Wednesday, May 5, the Davao City’s Property, Plant, and Equipment (PPE) accounts amounting to more than P9.48 billion “cannot be ascertained as to its validity, correctness and existence.”
“Amidst the COVID-19 pandemic restrictions, there was no CY 2020 RPCPPE (Report on the Physical Count of Property, Plant and Equipment) neither prepared, nor a physical inventory-taking was conducted as required by established rules and regulations, thus the difficulty to apply alternative audit procedures in determining the fairness of presentation of such PPE accounts in the financial statements at year-end,
Published May 6, 2021, 11:56 AM
The Department of Science and Technology (DOST) has announced that the team tasked to look into the efficacy and safety of Laguna tablets or syrup as a coronavirus disease (COVID-19) therapeutic or supplement is set to conduct its data analysis for its placebo-controlled clinical trial next week.
Lagundi (Manila Bulletin File Photo)
During President Duterte’s televised public briefing on Wednesday night, May 5, DOST Secretary Fortunato “Boy” T. de la Peña said the two-stage, randomized and placebo-controlled lagundi clinical trial is expected to be completed soon.
He said the overall aim of the 10 month-long project is to evaluate the efficacy and safety of Laguna tablet/syrup in patients without co-morbidities suspected or with confirmed mild COVID-19.